@article{25cb6a7bfabf4c98807d6d26d476d5f9,
title = "Interprofessional and interdisciplinary collaboration for early phase oncological clinical trials in academia—Myo-inositoltrispyrophophate as model",
author = "Regina Grossmann and Schneider, \{Marcel Andre\} and Michael Linecker and Lehn, \{Jean Marie\} and Claude Nicolau and Martin Traber and Fabian Tay and Diego Vicente and Alexander Jetter and Annette Mollet and Thomas Szucs and Rolf Graf and Clavien, \{Pierre Alain\} and Perparim Limani",
note = "Funding Information: The Clinical Trial Center Zurich is one of the Swiss Clinical Trial Units (CTUs) that are located at University Hospitals in Basel, Berne, Geneva, Lausanne, St. Gallen and Ticino [ 24 ]. It is an ISO 9001:2015 certified institute of the University Hospital Zurich. The CTC belongs to University Hospital Zurich and was established in 2007, supported by the Swiss National Science Foundation (SNSF) and the Swiss State Secretariat for Education, Research and Innovation (SERI). The main aim of the CTC is to support academic investigator-initiated research projects of the University Hospital Zurich and associated hospitals with highly qualified personnel to assure well-planned and robust scientific data and outcomes. Nationally, the CTC operates and collaborates with the other Swiss CTUs. This collaboration assures effective and successful conduct of (multicenter) research projects and enables research groups and scientists to ace international competition. In 2017, the CTU Network was involved in more than 390 multicenter studies and played a key role in all approved projects of the Investigator-initiated clinical trial (IICT) calls of the SNSF [ 25 ]. Funding Information: The Swiss Clinical Trial Organisation (SCTO) is the umbrella organization of the CTUs. It was founded as a joint initiative of the Swiss National Science Foundation and the Swiss Academy of Medical Sciences (SAMS). As of 2017, the SCTO is a research infrastructure of national importance funded by the State Secretariat of Education, Research and Innovation (SERI) and the SNSF. In order to harmonize quality and safety standards for research projects all over Switzerland, the SCTO coordinated the collaboration of the CTU Network with the Swiss Group for Clinical Cancer Research (SAKK) to develop the Good Operational Practice Guidelines [ 26 ]. ",
year = "2020",
month = apr,
doi = "10.1016/j.phrs.2019.04.022",
language = "English",
volume = "154",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press",
}